T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment

Metabolic signatures that align with depression phenotypes could better characterize the neurobiology of major depressive disorder (MDD) and its heterogeneity. We aimed to identify metabolomic markers of MDD phenotypes and their change after SSRI-treatment.

Source: Biological Psychiatry - May 13, 2019 Category: Psychiatry Authors: Ahmed T. Ahmed, Siamak Mahmoudian Dehkordi, Sudeepa Bhattacharyya, Matthias Arnold, Gregory Louie, Boadie Dunlop, Liewei Wang, Richard Weinshilboum, Ranga Krishnan, William V. Bobo, Patricio Riva Posse, W. Edward Craighead, William McDonald, Michelle K. S Source Type: research